Brookings launches tracker on Trump-era regulatory changes affecting health and AI Brookings has published a regulatory tracker covering new, delayed, and repea
Brookings has launched a new tracker to monitor regulatory changes enacted during the Trump administration, focusing on health and AI sectors. This initiative aims to provide clarity on new, delayed, and repealed rules, as well as related executive actions and court cases. While the direct impact is on the U.S., the tracker's insights are significant for African nations, influencing potential collaborations and compliance standards in health AI. AI
IMPACT Provides insight into regulatory shifts that could impact AI development and deployment in the health sector.